Home SAGE Therapeutics

SAGE Therapeutics

acquired
IPO Delisting
Biopharmaceutical Manufacturer

Basic Information

SAGE Therapeutics is a biopharmaceutical company dedicated to developing novel therapies with the potential to transform the lives of patients suffering from debilitating brain disorders. Seeking new approaches aimed at improving brain health, our depression, neurology, and neuropsychiatry franchise programs are designed to change how people perceive and treat brain disorders. Our mission is to create significant medicines so that people can recover more quickly.
SAGE Therapeutics, Inc
Cambridge,Massachusetts,United States of America
more than 500 people
January 01, 2010
careers@sagerx.com